Navigation Links
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
Date:12/7/2009

MOUNTAIN VIEW, Calif., Dec. 7 /PRNewswire/ -- In addition to data released in late November, ChemoCentryx, Inc., announced today more data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. While the earlier announcement concerned the Induction period of the study, new data from the Maintenance period of the study showed that a statistically significant number of patients receiving continuous therapy of Traficet-EN versus placebo for 36 weeks were in clinical remission of Crohn's disease, defined as a score of 150 points or less in the Crohn's Disease Activity Index (CDAI). At week 36, a statistically significant percentage of patients receiving Traficet-EN versus placebo were in corticosteroid-free remission. Traficet-EN continued to be safe and well-tolerated after extended use. Additionally, conclusive evidence was provided that the involvement of the CCR9 and its chemokine ligand (TECK) in inflammatory bowel disease (IBD) is not just restricted to the small bowel, but is relevant to inflammation of the large bowel as well.

The new Crohn's disease clinical remission findings, as well as the expanded understanding of the role of CCR9 and its ligand TECK in the gastrointestinal system (GI) tract, were highlighted in poster and oral presentations titled "PROTECT-1 Maintenance Phase Study Results Demonstrate Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease" and "CCR9 Inhibition in the Treatment of Colonic Inflammation" at the 2009 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's Clinical & Research Conference in Hollywood, Florida.

Traficet-EN is an orally-active antagonist of the chemokine receptor known as 'CCR9', which is selectively expressed by inflammatory T cells that migrate to the digestive t
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
2. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
7. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
8. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
11. Pharmasset Reports Fiscal Year End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/mp95jv/global_hearing ... "Global Hearing Aids Market 2015-2019" report to ... aids market to grow at a CAGR of ... Factors such as changing demographics and high prevalence ... market has witnessed immense technological advances. These factors, ...
(Date:7/28/2015)... 2015 Mike Rowe , spokesperson and reality ... Neighbor Pharmacy,s 2015 ThoughtSpot conference and tradeshow, ... Las Vegas, Nev. Best ... It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a ... heroes" – people whose hard work, sacrifice and value aren,t ...
(Date:7/28/2015)... (NYSE: CRY ), a leading medical device and ... announced today its results for the second quarter and ... Mackin, Chairman, President and Chief Executive Officer, said, "During ... strategy with solid progress on several of our top ... to a direct sales model in France, advancing our ...
Breaking Medicine Technology:Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14
(Date:7/28/2015)... ... July 28, 2015 , ... Autism is the fastest ... currently affected with the disorder. For these families, identifying and paying for the ... extremely daunting. That’s where Talk About Curing Autism (TACA), a national non-profit organization ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthline , a provider of ... survey (1) examining consumers’ perspectives on digital health . The survey, which was ... as innovations in digital health, level of trust in the security of digital health ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women in Technology (WIT), the ... community for over 20 years, has selected Lisa Dezzutti, CEO and president at Market ... “I am excited to serve this organization that empowers women to thrive and excel ...
(Date:7/28/2015)... ... July 28, 2015 , ... Master flutist and solo artist Gary ... around the world, in this collection of serene, restorative instrumental music. Tracks carefully ... yoga practice, for body work and more -- to help the listener deeply breathe ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic Laser Institute ... to a smooth state, and reduces the appearance of fine lines and wrinkles. , ... injectable gel to instantly add volume to your cheek area to correct age-related volume ...
Breaking Medicine News(10 mins):Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3
... drug-free way to treat agitation and depression among dementia patients, ... to know for sure, according to a review of recent ... during conversation helped ease agitation and restore appetite in dementia ... ,“Although the available reliable evidence supports the use of massage ...
... lead to the growth and spread of cancer. Controlling stress ... that stress results in the release of hormones that aggravate ... stimulates cancer cells to produce two compounds that can breakdown ... move easily into the bloodstream and travel to other parts ...
... a dramatic increase in the number of statin prescriptions in ... organised by the Royal College of Physicians of Edinburgh//. ... to offer a prescription than to persuade people to make ... a relatively low risk of heart disease were being put ...
... who inevitably convey the poisonous toxic meth chemicals to their ... novel Canadian Study. , ,Motherisk lab at the Hospital ... hair samples of adults and young children to gauge their ... is conveyed from the expectant mother to the unborn child. ...
... umbilical cord blood stem cells for the first time by ... drug testing. ,According to the scientists, this mini ... initial phase of generating segments that can be made use ... form. ,Scientists from Newcastle University worked in ...
... towards making healthcare more affordable, over 880 medicines including ... well as antibiotics would become cheaper. ,The new ... from Thursday with the government fixing the wholesale and ... of Chemicals and Fertiliser Ram Vilas Paswan said Tuesday ...
Cached Medicine News:Health News:Massage May Help Dementia Patients With Agitation 2Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Increased Warning over heart drugs 2Health News:Artificial Liver from Cord Blood Stem cells 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: